United States · FDA National Drug Code directory
LOTRONEX
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 54766-894_557ed953-bb9c-8e24-e063-6394a90a525f
- Product NDC
- 54766-894
- Form
- TABLET
- Composition / generic term
- alosetron hydrochloride
- Labeler
- Sebela Pharmaceuticals Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20160711
- Source listing expiry
- 20271231
Source-listed ingredients
- ALOSETRON HYDROCHLORIDE — .5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (54766-894-03) · 54766-894-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →